1. Home
  2. Clinical Topics
  3. FDA clears stereotactic radiotherapy system for treating breast cancer
Clinical TopicsDrugs and DevicesOncologyWeb Exclusives
breast cancer stereotactic radiotherapy gammapod fda treatment

FDA clears stereotactic radiotherapy system for treating breast cancer

Share

On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating breast cancer. However, it’s not as effective as whole breast radiation therapy, so isn’t intended to replace that.

Read more via Fda.gov.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts